Plasma B-Type Natriuretic Peptide Levels at Discharge and Their Decrease from Admission Are Associated with Worse Prognosis in Patients with Very Advanced Heart Failure

2009 ◽  
Vol 15 (6) ◽  
pp. S103
Author(s):  
Cesar A. Belziti ◽  
Sebastian Maldonado ◽  
Luis Gomez ◽  
Rodolfo Pizarro ◽  
Norberto Vulcano
Keyword(s):  
Heart Failure ◽  
Natriuretic Peptide ◽  
Advanced Heart Failure ◽  
Worse Prognosis

Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation

2009 ◽  
Vol 10 (9) ◽  
pp. 671-676 ◽  
Author(s):  
Carlo Campana ◽  
Michele Pasotti ◽  
Catherine Klersy ◽  
Giuseppe Alessandrino ◽  
Riccardo Albertini ◽  
...  
Keyword(s):  
Heart Failure ◽  
Natriuretic Peptide ◽  
Cardiac Transplantation ◽  
Advanced Heart Failure

The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide–Guided Therapy in Patients With Advanced Heart Failure

2011 ◽  
Vol 17 (8) ◽  
pp. 613-621 ◽  
Author(s):  
Monica R. Shah ◽  
Robert M. Califf ◽  
Anju Nohria ◽  
Manju Bhapkar ◽  
Margaret Bowers ◽  
...  
Keyword(s):  
Heart Failure ◽  
Pilot Study ◽  
Natriuretic Peptide ◽  
Advanced Heart Failure ◽  
Guided Therapy

Role of B-type natriuretic peptide (BNP) in heart failure

2017 ◽  
Vol 16 (1) ◽  
pp. 3-9 ◽  
Author(s):  
Md. Helal Uddin ◽  
Tasnuva Rashid ◽  
Salim Mahmud Chowdhury
Keyword(s):  
Heart Failure ◽  
Natriuretic Peptide ◽  
Signs And Symptoms ◽  
Urgent Care ◽  
Extensive Literature ◽  
Diagnostic Pathways ◽  
Worse Prognosis ◽  
Rule Out

Abstract Introduction: Early clinical diagnosis of heart failure (HF) is challenging because the signs and symptoms are neither sensitive nor specific for diagnosis. B-type natriuretic peptide (BNP), a cardiac neurohormone is a useful biomarker for patients with HF. Objectives: The purpose of this review is to evaluate the role of BNP in HF as a diagnostic, prognostic, and therapeutic marker in both outpatient care and urgent care settings. Methodology: An extensive literature review was conducted for this study. Findings: Determination of BNP is particularly useful as a rule-out test for suspected cases of HF in patients with dyspnoea. HF is very unlikely in patients with levels of BNP <100 pg/mL whereas BNP levels >400 pg/mL strongly support the diagnosis of HF. Elevated level of BNP indicates a worse prognosis in patients with HF. Conclusion: Although, it is recommended in the diagnostic pathways of guidelines for HF, it is not well established to recommend measurement of BNP to titrate HF medications because of lack of enough evidence. It requires further in-depth research.

Sign in / Sign up

Export Citation Format

Share Document